Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis

Journal of Hepatology

Volumn 58, Issue 5, 2013, Pages 1000-1006

  Bechmann, Lars P ^a,b   Vetter, Diana ^a   Ishida, Junichi ^c   Hannivoort, Rebekka A ^a,d   Lang, Ursula E ^a   Kocabayoglu, Peri ^a   Fiel, M Isabel ^a   Muñoz, Ursula ^a   Patman, Gillian L ^e   Ge, Fengxia ^f   Yakar, Shoshana ^a   Li, Xiaosong ^g   Agius, Loranne ^e   Lee, Young Min ^a   Zhang, Weijia ^a   Hui, Kei Yiu ^e   Televantou, Despina ^e   Schwartz, Gary J ^g   Leroith, Derek ^a   Berk, Paul D ^f   Nagai, Ryozo ^c   Suzuki, Toru ^c   Reeves, Helen L ^e   Friedman, Scott L ^a   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

CD36; KLF6; miRNA 10b; NAFLD; PEPCK; PPAR ; TRB3

Indexed keywords

GLUCOSE; INSULIN; KRUPPEL LIKE FACTOR 6; MESSENGER RNA; MICRORNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; CELL CULTURE; CONTROLLED STUDY; DEPLETION; FAT CONTENT; FATTY LIVER; GENE; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID DIET; LIVER; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEATOSIS;

ANIMALS; CELLS, CULTURED; COHORT STUDIES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FATTY LIVER; GLUCOSE; HUMANS; INSULIN; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PPAR ALPHA; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84876291629     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.01.020     Document Type: Article

References (36)

1. A.E. Feldstein Novel insights into the pathophysiology of nonalcoholic fatty liver disease Semin Liver Dis 30 2010 391 401
2. G. Narla, K.E. Heath, H.L. Reeves, D. Li, L.E. Giono, and A.C. Kimmelman KLF6, a candidate tumor suppressor gene mutated in prostate cancer Science 294 2001 2563 2566
3. S. Yea, G. Narla, X. Zhao, R. Garg, S. Tal-Kremer, and E. Hod Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma Gastroenterology 134 2008 1521 1531
4. T. Suzuki, T. Yamamoto, M. Kurabayashi, R. Nagai, Y. Yazaki, and M. Horikoshi Isolation and initial characterization of GBF, a novel DNA-binding zinc finger protein that binds to the GC-rich binding sites of the HIV-1 promoter J Biochem 124 1998 389 395
5. D. Li, S. Yea, S. Li, Z. Chen, G. Narla, and M. Banck Kruppel-like factor-6 promotes preadipocyte differentiation through histone deacetylase 3-dependent repression of DLK1 J Biol Chem 280 2005 26941 26952
6. W. Qi, X. Chen, J. Holian, C.Y. Tan, D.J. Kelly, and C.A. Pollock Transcription factors Kruppel-like factor 6 and peroxisome proliferator- activated receptor-{gamma} mediate high glucose-induced thioredoxin-interacting protein Am J Pathol 175 2009 1858 1867
7. L. Miele, G. Beale, G. Patman, V. Nobili, J. Leathart, and A. Grieco The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease Gastroenterology 135 2008 282 291 e281
8. L.P. Bechmann, A. Gastaldelli, D. Vetter, G.L. Patman, L. Pascoe, and R.A. Hannivoort Glucokinase links Kruppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease Hepatology 55 2012 1083 1093
9. L.P. Bechmann, R.A. Hannivoort, G. Gerken, G.S. Hotamisligil, M. Trauner, and A. Canbay The interaction of hepatic lipid and glucose metabolism in liver diseases J Hepatol 56 2012 952 964
10. P.D. Berk Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome Hepatology 48 2008 1362 1376
11. D.R. Cha, J.Y. Han, D.M. Su, Y. Zhang, X. Fan, and M.D. Breyer Peroxisome proliferator-activated receptor-alpha deficiency protects aged mice from insulin resistance induced by high-fat diet Am J Nephrol 27 2007 479 482
12. K.R. Stayrook, K.S. Bramlett, R.S. Savkur, J. Ficorilli, T. Cook, and M.E. Christe Regulation of carbohydrate metabolism by the farnesoid X receptor Endocrinology 146 2005 984 991
13. L. Zheng, G.C. Lv, J. Sheng, and Y.D. Yang Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD J Gastroenterol Hepatol 25 2010 156 163
14. L. Ma, J. Teruya-Feldstein, and R.A. Weinberg Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 2007 682 688
15. S.H. Koo, H. Satoh, S. Herzig, C.H. Lee, S. Hedrick, and R. Kulkarni PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3 Nat Med 10 2004 530 534
16. D. Weismann, D.M. Erion, I. Ignatova-Todorava, Y. Nagai, R. Stark, and J.J. Hsiao Knockdown of the gene encoding Drosophila tribbles homologue 3 (Trib3) improves insulin sensitivity through peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation in a rat model of insulin resistance Diabetologia 54 2011 935 944
17. C.C. Leow, B.E. Wang, J. Ross, S.M. Chan, J. Zha, and R.A. Carano Prostate-specific Klf6 inactivation impairs anterior prostate branching morphogenesis through increased activation of the Shh pathway J Biol Chem 284 2009 21057 21065
18. D. Vetter, M. Cohen-Naftaly, A. Villanueva, Y.A. Lee, P. Kocabayoglu, and R. Hannivoort Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing Hepatology 56 4 2012 1361 1370
19. M. Tarocchi, R. Hannivoort, Y. Hoshida, U.E. Lee, D. Vetter, and G. Narla Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation Hepatology 54 2011 522 531
20. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
21. C. Postic, and M.A. Magnuson DNA excision in liver by an albumin-Cre transgene occurs progressively with age Genesis 26 2000 149 150
22. K. Du, S. Herzig, R.N. Kulkarni, and M. Montminy TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver Science 300 2003 1574 1577
23. J.G. Ruby, C.H. Jan, and D.P. Bartel Intronic microRNA precursors that bypass Drosha processing Nature 448 2007 83 86
24. M.V. Chakravarthy, I.J. Lodhi, L. Yin, R.R. Malapaka, H.E. Xu, and J. Turk Identification of a physiologically relevant endogenous ligand for PPARalpha in liver Cell 138 2009 476 488
25. W. Qi, J. Holian, C.Y. Tan, D.J. Kelly, X.M. Chen, and C.A. Pollock The roles of Kruppel-like factor 6 and peroxisome proliferator-activated receptor-gamma in the regulation of macrophage inflammatory protein-3alpha at early onset of diabetes Int J Biochem Cell Biol 43 2010 383 392
26. H.A. Hirsch, D. Iliopoulos, A. Joshi, Y. Zhang, S.A. Jaeger, and M. Bulyk A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases Cancer Cell 17 2010 348 361
27. K. Tomita, T. Teratani, T. Suzuki, T. Oshikawa, H. Yokoyama, and K. Shimamura P53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice J Hepatol 57 2012 837 843
28. S.H. Ibrahim, Y. Akazawa, S.C. Cazanave, S.F. Bronk, N.A. Elmi, and N.W. Werneburg Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis J Hepatol 54 2011 765 772
29. U.E. Lang, P. Kocabayoglu, G.Z. Cheng, Z. Ghiassi-Nejad, U. Munoz, and D. Vetter GSK3beta phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21 Oncogene 2012 10.1038/onc.2012.457
30. N. Tanaka, K. Moriya, K. Kiyosawa, K. Koike, F.J. Gonzalez, and T. Aoyama PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice J Clin Invest 118 2008 683 694
31. H. Oberkofler, A. Pfeifenberger, S. Soyal, T. Felder, P. Hahne, and K. Miller Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans Diabetologia 53 2010 1971 1975
32. P. She, M. Shiota, K.D. Shelton, R. Chalkley, C. Postic, and M.A. Magnuson Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism Mol Cell Biol 20 2000 6508 6517
33. S.Q. Yang, H.Z. Lin, A.K. Mandal, J. Huang, and A.M. Diehl Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology Hepatology 34 2001 694 706
34. P. She, S.C. Burgess, M. Shiota, P. Flakoll, E.P. Donahue, and C.R. Malloy Mechanisms by which liver-specific PEPCK knockout mice preserve euglycemia during starvation Diabetes 52 2003 1649 1654
35. L.P. Bechmann, R.K. Gieseler, J.P. Sowa, A. Kahraman, J. Erhard, and I. Wedemeyer Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis Liver Int 30 2010 850 859
36. Z. Derdak, K.A. Villegas, R. Harb, A.M. Wu, A. Sousa, and J.R. Wands Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease J Hepatol 2012 10.1016/j.jhep.2012.11.042